Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 9)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 9)

Results 161 - 180 of 2,336 in Lipitor, Atorvastatin (generic)

  1. Lipitor Lawsuit Filings Surpass 1,300 Cases in Federal Diabetes...Read the original story w/Photo

    Oct 27, 2014 | PRWeb

    The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of the statin medication. Our Firm continues to hear from Lipitor patients on a fairly regular basis who claim they developed Type 2 diabetes due to their use of this medication.


  2. Dr. Roach: Metal joins in MRIL sleuthing safetyRead the original story w/Photo

    Oct 26, 2014 |

    DEAR DR. ROACH: I am considering minimally invasive spine surgery. Almost 19 years ago, I had a right total-knee replacement, which still functions very well.


  3. Hormone replacement therapy and statins: what every woman should knowRead the original story w/Photo

    Oct 23, 2014 |

    The objective of the study was to examine the effects of HRT on the risk of cardiovascular outcomes and all-cause mortality in women treated with statins In their menopausal years, many women take statins and/or hormone replacement therapy . A new study evaluated the use of HRT and cardiovascular risk among women under treatment with statins.


  4. High-intensity statins cut diabetic atherosclerosisRead the original story w/Photo

    Oct 21, 2014 | PhysOrg Weblog

    High-intensity statin therapy can alter the progressive nature of diabetic atherosclerosis, according to a study published online Sept. 4 in Diabetes Care .


  5. Chronic unilateral chemosis following the use of amlodipine besylateRead the original story

    Oct 21, 2014 | BioMed Central

    A 52-year-old man visited the clinic with symptoms of foreign body sensation and puffiness in his right eye, which had persisted for 4 months. There were no other symptoms, such as itching and pain, in his right eye and no specific symptoms in his left eye.


  6. Medicare Plan Finder: a step-by-step guideRead the original story w/Photo

    Oct 20, 2014 | St. Petersburg Times

    Television ads for Medicare plans usually feature vital, robust people touting why their XYZ plan is just terrific. They love their doctors.


  7. Don't believe the misleading attacks aimed at keeping safe, affordable drugs from MainersRead the original story w/Photo

    Oct 19, 2014 | Bangor Daily News

    A recent opinion column in the Bangor Daily News shows the extent to which the Maine Pharmacy and Maine Retail associations will go to protect their profits while restricting access to affordable and lifesaving medications for Mainers.


  8. Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?Read the original story w/Photo

    Oct 18, 2014 | The Motley Fool

    The biopharmaceutical realm is a world filled with numerous hits and misses. But if you imagine the sphere of hits versus the sphere of misses, you're probably comparing something the size of a basketball to an object the size of the Earth .


  9. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.Read the original story

    Oct 18, 2014 | CiteULike

    Patients undergoing vascular surgery are a high-risk population with widespread atherosclerosis, an adverse cardiovascular risk profile and often multiple co-morbidities. Postoperative cardiovascular complications, including myocardial infarct , are common.


  10. Effect of atorvastatin on the expression of gamma-glutamyl...Read the original story

    Oct 18, 2014 | BioMed Central

    Gamma-glutamyl transpeptidase is now considered to be one of the risk factors for cardiovascular disease. However, whether statins can alter GGT levels in arterial atheromatous plaque has not yet been studied.


  11. Cadila recalls drug in USRead the original story w/Photo

    Oct 17, 2014 | The Telegraph

    Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration said the recall was voluntarily initiated by the company through its US arm Zydus Pharmaceuticals.


  12. Don Cayo: B.C. has saved a bundle on generic drugs, yet we still pay way too muchRead the original story w/Photo

    Oct 16, 2014 | Vancouver Sun

    Vancouver chef Lesley Kim was walking to a party from her home in Gastown last Halloween when a firecracker struck her in the face, blinding her in her left eye. Within weeks of her accident she organized Spectacle, a gala that raised more than $130,000 for Seva Canada, an organization that focuses on blindness prevention and provides cataract surgeries in developing countries.


  13. DSM cuts out China's ATS-8 intermediate middlemen with enzyme-made statin APIsRead the original story w/Photo

    Oct 14, 2014 | Drug Researcher

    Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers. The new active pharmaceutical ingredient is a version of rosuvastatin, the active in AstraZeneca's Crestor, that is produced using an enzymatic process that requires fewer solvents, and eliminates buthyl-lithuim entirely.


  14. Major health campaign starts to tackle one of Bradford's biggest killersRead the original story w/Photo

    Oct 16, 2014 | Thetelegraphand Argus

    A MAJOR campaign to help tackle the one of the biggest killers in Bradford has been announced by health leaders. Bradford's Healthy Hearts project has been developed to reduce the risk of stroke and heart attack in people who are considered to be at risk.


  15. Atorvastatin Reduces the Proadhesive and Prothrombotic Endothelial...Read the original story

    Oct 15, 2014 | Circulation

    From the Hematology-Oncology Department, Faculty of Medicine and Pharmacy Department, Chemistry Faculty , Pontificia Universidad CatA3lica de Chile, Santiago, Chile; and Nuclear Medicine Section, Medicine Department, University of Chile Clinical Hospital, Santiago, Chile . Correspondence to Jaime Pereira, MD, Department of Hematology-Oncology, School of Medicine, Pontificia Universidad CatA3lica de Chile, Santiago, Chile.


  16. Chemically induced mouse liver tumors are resistant to treatment with atorvastatinRead the original story

    Oct 15, 2014 | BioMed Central

    Atorvastatin is a potent inhibitor of the mevalonate pathway and widely used as a hypolipidemic drug. Some epidemiological studies and animal experiments indicate that the long-term use of atorvastatin and structurally related drugs might be associated with a reduced risk of developing hepatocellular carcinoma , the most common hepatocellular malignancy in humans.


  17. Canada pays too much for generic drugs: studyRead the original story w/Photo

    Oct 14, 2014 | Barriere Star Journal

    Canada is still paying far more than other industrialized countries for generic drugs, despite recent efforts by the provinces and territories to cuts costs by bulk-buying six particularly costly medications, a new study has found. The study by the University of Ottawa and the Bruyere Research Institute says the price tags on the six drugs - which include medications for high blood pressure and high cholesterol - remain much higher in Canada than they are elsewhere.


  18. Canadians In Distress As Essential Generic Drug Prices Are SoaringRead the original story w/Photo

    Oct 14, 2014 | International Business Times

    Canada is facing a serious problem of escalating prices of generic drugs that are 60 to 70 percent cheaper in other industrialised countries. The problem is more acute in the case of six essential drugs.


  19. Ontario health minister pledges review of generic drug costsRead the original story w/Photo

    Oct 14, 2014 | The Toronto Star

    Ontario Health Minister Eric Hoskins has asked his ministry to review a new study showing Canada pays more than double for common generic drugs compared to other developed countries. Health critics have called for a review of the purchasing system for the drugs in the wake of the study, published Tuesday.


  20. Provinces overpay for generic drugs, study findsRead the original story w/Photo

    Oct 14, 2014 | CBC News

    University of Ottawa associate professor Amir Attaran is co-author of a study of how much countries pay for generic drugs. Canada pays too much, he says.